Cargando…

Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program

IMPORTANCE: As cervical cancer screening transitions from Papanicolaou cytologic screening to primary human papillomavirus (HPV) testing worldwide, effective triage tests are needed to decide who among the HPV-positive women should receive further diagnostic evaluation to avoid unnecessary colposcop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wentzensen, Nicolas, Clarke, Megan A., Bremer, Renee, Poitras, Nancy, Tokugawa, Diane, Goldhoff, Patricia E., Castle, Philip E., Schiffman, Mark, Kingery, Julie D., Grewal, Kiranjit K., Locke, Alex, Kinney, Walter, Lorey, Thomas S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515572/ https://www.ncbi.nlm.nih.gov/pubmed/31081870 http://dx.doi.org/10.1001/jamainternmed.2019.0306

Ejemplares similares

Accuracy and Efficiency of Deep-Learning–Based Automation of Dual Stain Cytology in Cervical Cancer Screening
por: Wentzensen, Nicolas, et al.
Publicado: (2020)

Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines
por: Demarco, Maria, et al.
Publicado: (2017)

p16/Ki-67 dual-stained cytology used for triage in cervical cancer opportunistic screening
por: Han, Qin, et al.
Publicado: (2020)

The Role of p16/Ki67 Dual Staining in Cervical Cancer Screening
por: Dovnik, Andraž, et al.
Publicado: (2023)

Approaches to triage optimization in HPV primary screening: Extended genotyping and p16/Ki‐67 dual‐stained cytology—Retrospective insights from ATHENA
por: Stoler, Mark H., et al.
Publicado: (2019)

Screening for Cervical Cancer Precursors With p16/Ki-67 Dual-Stained Cytology: Results of the PALMS Study
por: Ikenberg, Hans, et al.
Publicado: (2013)

Triaging HPV-Positive Cervical Samples with p16 and Ki-67 Dual Stained Cytology within an Organized Screening Program—A Prospective Observational Study from Western Norway
por: Øvestad, Irene Tveiterås, et al.
Publicado: (2023)

Triage Strategies for Non-16/Non-18 HPV-Positive Women in Primary HPV-Based Cervical Cancer Screening: p16/Ki67 Dual Stain vs. Cytology
por: Mazurec, Karolina, et al.
Publicado: (2023)

Low Risk of Cervical Cancer/Precancer Among Most Women Under Surveillance Postcolposcopy
por: Demarco, Maria, et al.
Publicado: (2018)

Clinical validation of p16/Ki‐67 dual‐stained cytology triage of HPV‐positive women: Results from the IMPACT trial
por: Wright, Thomas C., et al.
Publicado: (2021)

p16(INK4a)/Ki-67 dual stain cytology for cervical cancer screening in Thika district, Kenya
por: Ngugi, Caroline Wangari, et al.
Publicado: (2015)

Human Papillomavirus Detection and Abnormal Anal Cytology in HIV-infected Patients Using p16/Ki-67 Dual-Staining
por: Patarapadungkit, Natcha, et al.
Publicado: (2020)

The Improving Risk Informed HPV Screening (IRIS) Study: Design and Baseline Characteristics
por: Gage, Julia C., et al.
Publicado: (2022)

Cervical Screening Performance
por: Schiffman, Mark, et al.
Publicado: (2021)

Implementation of p16/Ki67 dual stain cytology in a Danish routine screening laboratory: Importance of adequate training and experience
por: Hammer, Anne, et al.
Publicado: (2020)

Application of p16/Ki-67 dual-staining cytology in cervical cancers
por: Yu, Li, et al.
Publicado: (2019)

Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study
por: Uijterwaal, M H, et al.
Publicado: (2014)

A Comparative Study on the Accuracy and Efficacy Between Dalton and CINtec(®) PLUS p16/Ki-67 Dual Stain in Triaging HPV-Positive Women
por: Li, Ying, et al.
Publicado: (2022)

Liquid-Based Screening Tests Results: HPV, Liquid-Based Cytology, and P16/Ki67 Dual-Staining in Private-Based Opportunistic Cervical Cancer Screening
por: Trzeszcz, Martyna, et al.
Publicado: (2021)

A Study of Partial Human Papillomavirus Genotyping in Support of the 2019 ASCCP Risk-Based Management Consensus Guidelines
por: Demarco, Maria, et al.
Publicado: (2020)

Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting
por: Landy, Rebecca, et al.
Publicado: (2019)

A cocktail of p16(INK4a) and Ki-67, p16(INK4a) and minichromosome maintenance protein 2 as triage tests for human papillomavirus primary cervical cancer screening
por: Wang, Hai-Rui, et al.
Publicado: (2017)

Automated Ki-67 Quantification of Immunohistochemical Staining Image of Human Nasopharyngeal Carcinoma Xenografts
por: Shi, Peng, et al.
Publicado: (2016)

Comparative Assessment of p16/Ki-67 Dual Staining Technology for cervical cancer screening in women living with HIV (COMPASS-DUST)–Study protocol
por: Okunade, Kehinde S., et al.
Publicado: (2023)

Cost-effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-testing with hrHPV Genotyping for Cervical Cancer Screening
por: Harper, Diane M., et al.
Publicado: (2023)

Human Papillomavirus (HPV)-Associated Squamous Cell Carcinoma In situ With Positive p16 and Ki-67 Immunohistochemical Stains in a Young Immunocompetent Patient
por: Chandra, Aditi, et al.
Publicado: (2020)

P16/Ki-67 Dual Staining in Positive Human Papillomavirus DNA Testing for Predictive Diagnosis of Abnormal Cervical Lesions in Northeastern Thai Women
por: Aromseree, Sirinart, et al.
Publicado: (2022)

Predictive value of p16/Ki-67 immunocytochemistry for triage of women with abnormal Papanicolaou test in cervical cancer screening: a systematic review and meta-analysis
por: Chen, Cheng-Chieh, et al.
Publicado: (2016)

Content-based analysis of Ki-67 stained meningioma specimens for automatic hot-spot selection
por: Swiderska-Chadaj, Zaneta, et al.
Publicado: (2016)

Generative Adversarial Domain Adaptation for Nucleus Quantification in Images of Tissue Immunohistochemically Stained for Ki-67
por: Zhang, Xuhong, et al.
Publicado: (2020)

Spontaneous expression of the gene of KI67 and P53 in cynomolgus monkeys infected with papillomavirus
por: Darusman, Huda S., et al.
Publicado: (2022)

Predict Ki-67 Positive Cells in H&E-Stained Images Using Deep Learning Independently From IHC-Stained Images
por: Liu, Yiqing, et al.
Publicado: (2020)

Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines
por: Egemen, Didem, et al.
Publicado: (2020)

A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs
por: Demarco, Maria, et al.
Publicado: (2020)

Interobserver variability and accuracy of p16/Ki-67 dual immunocytochemical staining on conventional cervical smears
por: Kloboves Prevodnik, Veronika, et al.
Publicado: (2019)

Is Primary HPV with Secondary p16/Ki67 Dual-Stain an Alternative HSIL-Risk Detection Strategy in Cervical Cancer Screening for Women under 30 Years?
por: Trzeszcz, Martyna, et al.
Publicado: (2021)

Significance of Triple Detection of p16/ki-67 Dual-Staining, Liquid-Based Cytology and HR HPV Testing in Screening of Cervical Cancer: A Retrospective Study
por: Yu, Li, et al.
Publicado: (2022)

Screening for precancerous anal lesions with P16/Ki67 immunostaining in HIV-infected MSM
por: Serrano-Villar, Sergio, et al.
Publicado: (2017)

Diagnostic Accuracy of Conventional Cell Blocks Along with p16INK4 and Ki67 Biomarkers as Triage Tests in Resource-poor Organized Cervical Cancer Screening Programs
por: Desai, Fanny, et al.
Publicado: (2019)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tehk0778pthsq2pcc6a5ceslf4